Joseph Romano
Gründer bei Lucid Psycheceuticals, Inc.
Profil
Joseph L.
Romano is the founder of Lucid Psycheceuticals, Inc. and Romano Law.
Prior to this, he served as an Independent Director at FSD Pharma, Inc. He completed his undergraduate degree at Osgoode Hall Law School.
Aktive Positionen von Joseph Romano
| Unternehmen | Position | Beginn |
|---|---|---|
Lucid Psycheceuticals, Inc.
 Lucid Psycheceuticals, Inc. Medical/Nursing ServicesHealth Services Part of FSD Pharma, Inc., Lucid Psycheceuticals, Inc. is a biotech company based in Toronto, CA. Lucid Psycheceuticals was acquired by FSD Pharma, Inc. on September 21, 2021 for $6.64 million. Lucid Psycheceuticals is exploring novel therapies to address total brain health, including mental health disorders and neurodegenerative disorders. The Canadian company has two active pipelines under development and is inspired by the mechanisms of action of psychedelics to prevent and possibly reverse neurodegeneration. The company was founded by Lakshmi P. Kotra and Joseph L. Romano, with Lakshmi P. Kotra serving as the CEO since incorporation. | Gründer | - |
| Romano Law | Gründer | - |
Ehemalige bekannte Positionen von Joseph Romano
| Unternehmen | Position | Ende |
|---|---|---|
| FSD PHARMA INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Joseph Romano
| Osgoode Hall Law School | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| FSD PHARMA INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Lucid Psycheceuticals, Inc.
Lucid Psycheceuticals, Inc. Medical/Nursing ServicesHealth Services Part of FSD Pharma, Inc., Lucid Psycheceuticals, Inc. is a biotech company based in Toronto, CA. Lucid Psycheceuticals was acquired by FSD Pharma, Inc. on September 21, 2021 for $6.64 million. Lucid Psycheceuticals is exploring novel therapies to address total brain health, including mental health disorders and neurodegenerative disorders. The Canadian company has two active pipelines under development and is inspired by the mechanisms of action of psychedelics to prevent and possibly reverse neurodegeneration. The company was founded by Lakshmi P. Kotra and Joseph L. Romano, with Lakshmi P. Kotra serving as the CEO since incorporation. | Health Services |
| Romano Law |
